Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progenitor Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04429763
What this trial is testing

Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia

Who this might be right for
COVID-19
Trustem 30
Not applicableUnknownNCT04728906
What this trial is testing

Heart Patch for Myocardial Infarction COVID-19

Who this might be right for
Myocardial InfarctionHeart Diseases
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto 10
Testing effectiveness (Phase 2)Study completedNCT01355133
What this trial is testing

Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

Who this might be right for
Stress Urinary Incontinence
University Medical Centre Ljubljana 40
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Early research (Phase 1)Study completedNCT02611063
What this trial is testing

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Stefanie Sarantopoulos, MD, PhD. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05167721
What this trial is testing

Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Mayo Clinic 71
Not applicableLooking for participantsNCT07794514
What this trial is testing

Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)cGVHDHepatic cGVHD+2 more
First Affiliated Hospital of Zhejiang University 170
Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00031148
What this trial is testing

Keratinocyte Growth Factor to Prevent Acute GVHD

Who this might be right for
Graft-vs-Host Disease
FDA Office of Orphan Products Development 72
Not applicableUnknownNCT02520908
What this trial is testing

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis

Who this might be right for
Epidermotropic T-cell Lymphomas
Assistance Publique - Hôpitaux de Paris 98
Not applicableStudy completedNCT03135925
What this trial is testing

Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation

Who this might be right for
Myeloma
Sheffield Teaching Hospitals NHS Foundation Trust 23
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752
What this trial is testing

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia
Shanghai Jiao Tong University School of Medicine 20
Early research (Phase 1)Study completedNCT02221258
What this trial is testing

Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 9
Testing effectiveness (Phase 2)Looking for participantsNCT06959771
What this trial is testing

Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study

Who this might be right for
CD40L-HyperIgM Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1
Not applicableStudy completedNCT03602599
What this trial is testing

Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

Who this might be right for
Graft Versus Host Disease
National Institute of Dental and Craniofacial Research (NIDCR) 190
Very early researchWithdrawnNCT03692221
What this trial is testing

Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease

Who this might be right for
Disc Degeneration
University Hospitals Cleveland Medical Center
Testing effectiveness (Phase 2)Study completedNCT00076752
What this trial is testing

Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00110058
What this trial is testing

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT02047578
What this trial is testing

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

Who this might be right for
Acute Lymphoblastic Leukemia
Seoul National University Hospital 38
Not applicableStudy completedNCT00889278
What this trial is testing

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
Dartmouth-Hitchcock Medical Center 30
Next Page